Benztropine 0.5 mg Tablets — Generic For Cogentin — Leading Pharma

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Benztropine mesylate tablets are prescription oral tablets available in 0.5 mg, 1 mg, and 2 mg strengths. The label says they are used as an adjunct in the therapy of all forms of parkinsonism and also to help control certain extrapyramidal disorders caused by neuroleptic drugs, except tardive dyskinesia.

The medicine has anticholinergic effects, and the label notes that these effects are the ones considered therapeutically important for parkinsonism. It contains inactive ingredients including corn starch, dicalcium phosphate anhydrous, hydrogenated vegetable oil, lactose anhydrous, lactose monohydrate, microcrystalline cellulose, and talc.

The label warns that this drug should not be used in people with hypersensitivity to benztropine mesylate or any tablet component, and it is contraindicated in children under 3 years of age. Caution is advised in older pediatric patients and in people with certain conditions such as glaucoma, tachycardia, or prostatic hypertrophy.

Commonly reported adverse reactions include dry mouth, constipation, nausea, vomiting, blurred vision, dilated pupils, urinary retention, confusion, hallucinations, and tachycardia. Serious reactions mentioned in the label include hyperthermia, heat stroke, paralytic ileus, and toxic psychosis.

Storage Information

Store at 20° to 25° C (68° to 77°F); excursions permitted to 15° to 30° C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in well-closed containers as defined in the USP.

Key Counseling Points

• Take this medicine exactly as prescribed; the label says dosing is individualized and may be started low and increased gradually.
• Do not stop other antiparkinsonian medicines suddenly when benztropine is started; the label says changes should be gradual.
• Tell a healthcare professional if you have trouble urinating, severe dry mouth, constipation, blurred vision, confusion, or hallucinations.
• Use caution with activities that require alertness, since the label says the medicine may impair mental and physical abilities needed for driving or operating machinery.
• Seek prompt attention for fever, heat intolerance, or signs of overheating, especially if this medicine is used with other anticholinergic or antipsychotic drugs.
• The label says this medicine is not recommended for tardive dyskinesia.
• Report any rash or other allergic reaction, especially if it does not improve with dose reduction.
• The label advises careful observation in patients with mental disorders, glaucoma, prostatic hypertrophy, or a tendency to tachycardia.
• Keep out of reach of children.

Helpful Patient Education

Benztropine mesylate tablets USP are oral tablets available in 0.5 mg, 1 mg, and 2 mg strengths. According to the DailyMed label, this medicine is used as an adjunct in the treatment of parkinsonism and for some drug-induced extrapyramidal disorders caused by neuroleptic medicines, except tardive dyskinesia.

Educational product information also notes important safety warnings and adverse reactions described on the label, including dry mouth, constipation, blurred vision, urinary retention, confusion, hallucinations, and overheating. Use is not recommended for children under 3 years of age, and the label advises caution in several conditions and when taken with certain other medicines.

Medication Summary last generated: 2026-07-10 02:58:05